PATIENT-REPORTED EXPERIENCES WITH SELF-INJECTIONS USING PREFILLED SYRINGE AND AUTOINJECTOR DEVICES IN AN OPEN-LABEL, LONG-TERM STUDY OF GALCANEZUMAB IN PATIENTS WITH MIGRAINE

被引：0
|
作者：
Stauffer, V. L. [1 ]
Sides, R. [1 ]
Lanteri-Minet, M. [2 ]
Kielbasa, W. [1 ]
Jin, Y. [1 ]
Selzler, K. J. [1 ]
Tepper, S. J. [3 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Ctr Hosp Univ Nice, Nice, France
[3] Geisel Sch Med Dartmouth, Hanover, NH USA
来源：
CEPHALALGIA | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [21] Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results from a Long-Term Open-Label Safety Study
    Schim, Jack
    Hutchinson, Susan
    Lipton, Richard
    Croop, Robert
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Lovegren, Meghan
    Coric, Vlad
    Jensen, Christopher
    NEUROLOGY, 2021, 96 (15)
  • [22] Long-term quality-of-life and patient-reported improve-ments with garadacimab for hereditary angioedema: Phase 3 open-label extension study
    Aygoeren-Puersuen, E.
    Chapdelain, H.
    Sitz, K.
    Katelaris, C. H.
    Staubach, P.
    Magerl, M.
    Saguer, I. Martinez
    Guilarte, M.
    Longhurst, H.
    Lawo, J. -P
    Braverman, J.
    Lumry, W. R.
    ALLERGOLOGIE, 2024, 47 (09)
  • [23] Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States
    Berman, Gary
    Thiry, Alexandra
    Croop, Robert
    JOURNAL OF PAIN RESEARCH, 2024, 17 : 1805 - 1814
  • [24] OPEN-LABEL STUDY OF LONG-TERM EFFECTIVENESS OF CISAPRIDE IN PATIENTS WITH IDIOPATHIC GASTROPARESIS
    DWORKIN, BM
    ROSENTHAL, WS
    CASELLAS, AR
    GIROLOMO, R
    LEBOVICS, E
    FREEMAN, S
    CLARK, SB
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) : 1395 - 1398
  • [25] A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis
    Davidson, M
    Harvey, PD
    Vervarcke, J
    Gagiano, CA
    De Hooge, JD
    Bray, G
    Dose, M
    Barak, Y
    Haushofer, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (06) : 506 - 514
  • [26] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [27] Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience
    Duffin, Kristina Callis
    Bukhalo, Michael
    Bobonich, Margaret A.
    Shrom, David
    Zhao, Fangyi
    Kershner, James R.
    Gill, Anne
    Pangallo, Beth
    Shuler, Catherine L.
    Bagel, Jerry
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2016, 9 : 361 - 369
  • [28] Perampanel Study 207: long-term open-label evaluation in patients with epilepsy
    Rektor, I.
    Krauss, G. L.
    Bar, M.
    Biton, V.
    Klapper, J. A.
    Vaiciene-Magistris, N.
    Kuba, R.
    Squillacote, D.
    Gee, M.
    Kumar, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2012, 126 (04): : 263 - 269
  • [29] Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study
    Mark G. Lebwohl
    Andrew Blauvelt
    Alan Menter
    Kim A. Papp
    Scott Guenthner
    Radhakrishnan Pillai
    Robert J. Israel
    Abby Jacobson
    American Journal of Clinical Dermatology, 2019, 20 : 863 - 871
  • [30] Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study
    Lebwohl, Mark G.
    Blauvelt, Andrew
    Menter, Alan
    Papp, Kim A.
    Guenthner, Scott
    Pillai, Radhakrishnan
    Israel, Robert J.
    Jacobson, Abby
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (06) : 863 - 871
12345